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Melodic Intonation Therapy in subacute aphasia 
 
Introduction 
Melodic Intonation Therapy (MIT)
1 
is based on the observation that persons with severe 
nonfluent aphasia are often able to sing words or even short phrases they cannot produce 
during speech. MIT uses the melodic elements of speech, such as intonation and rhythm, to 
facilitate and improve language production. Although clinicians disagree about the usefulness 
of MIT, it has been translated into several languages and is frequently applied worldwide. 
Many studies have reported successful application of MIT.
2-4
 However, most studies are case-
studies without control condition in chronic patients. Hence, the level of evidence for MIT is 
low and little is known about its effect in earlier phases post stroke, when treatment interacts 
with processes of spontaneous recovery.
5
  
We examined MIT in the subacute phase post stroke. The purpose of this multicenter study 
was threefold. First, we evaluated the efficacy of MIT in the subacute phase. Further, we 
examined the effect of the timing of MIT in this early phase post stroke. Thirdly, we 
investigated potential determinants influencing therapy outcome.  
 
Method 
Design 
An observer-blinded waiting-list randomized controlled design was used (Figure 1). Patients 
in the experimental group received six weeks intensive MIT (5 h/wk). After completion of 
MIT, the choice of treatment was free. Patients in the control group received six weeks 
control therapy (5h/wk), followed by six weeks MIT (5h/wk). Assessments were performed at 
baseline (T1), after the first treatment phase of six weeks (T2) and six weeks later (T3) 
(Figure 1). 
 
Participants 
Participants were recruited in 15 aphasia treatment services from 2009-2011. Inclusion 
criteria were: aphasia after left hemisphere stroke, time post stroke 2-3 months, premorbidly 
right-handed, age 18-80, native speaker of Dutch, MIT candidate. MIT candidacy is defined 
in the literature as non-fluent aphasia, language repetition severely disordered, articulation 
deficits, moderate to good auditory comprehension.
6
 Exclusion criteria were: prior stroke 
resulting in aphasia, bilateral lesion, intensive MIT prior to start of the study, severe hearing 
deficit, premorbid dementia, psychiatric history relevant to language communication.  
 
Interventions 
In MIT, aphasic patients and the speech language therapist (SLT) together sing short phrases 
(e.g. How are you?), while tapping the rhythm with their left hand. Gradually, the support 
from the SLT decreases and singing is replaced by speaking. During MIT no other language 
therapy was allowed. The control intervention did not focus on verbal production, but on 
other linguistic modalities usually trained in severe aphasia: writing, language 
comprehension, and nonverbal communication..  
 
Outcome measures 
Outcome measures were the Sabadel story retell task
7
, the Amsterdam-Nijmegen Test for 
Everyday Language (ANELT)
8
, Aachen Aphasia Test
9
 subtests naming, repetition and 
comprehension, the MIT repetition task. This latter task was designed for this study and 
comprises 11 trained utterances and 11 matched untrained utterances, to examine the direct 
effect of MIT on the repetition of trained utterances and its generalization to untrained 
material. Naming was assessed to examine further generalization to word production. 
Generalization to functional language use was examined by the ANELT and the Sabadel, 
respectively assessing verbal production in daily life communicative situations and the 
production of connected speech.  
 
Results 
A total number of 27 patients were included in the study, 16 were allocated to the 
experimental group (direct MIT) and 11 to the control group (delayed MIT). Figure 1 
illustrates the CONSORT diagram of patient flow.  
 
Efficacy 
At T2, the MIT group showed significant improvement on all outcome measures, except the 
Sabadel. By contrast, the control group showed significant improvement only on the MIT 
repetition task. A linear regression analysis, corrected for baseline, revealed a significant 
difference in improvement at T2 between the MIT group and the control group on the MIT 
repetition task (β=18.3, p=.007). The difference between both interventions was significant 
for trained (β=15.0, p=.001), but not for untrained items (β=3.3, p=.249). Further, a trend for 
the improvement on the ANELT, in favor of the MIT group (β=4.1, p=.067) was observed.  
The mean improvement in the MIT group was 6.6 points, approaching the clinically relevant 
difference of 7 points as defined in the ANELT
8
,  versus 2.3 points in the control group.  
 
Timing 
Compared to the experimental group that received MIT immediately after inclusion, at 2.5 
months post onset (T1-T2), the control group started MIT six weeks later (T2-T3). A mixed 
model analysis examining differences over time (T1, T2, T3) showed a main effect of time for 
all outcome measures, indicating that language production improved over time in both 
intervention groups. When comparing both groups, only the T1-T2 MIT group showed a 
significant effect of time on the AAT naming task (F=19.92, p<0.001), the ANELT (F=8.81, 
p=.004) and the Sabadel (F=5.30, p=.02). Figure 2 illustrates the improvement on these 
outcome measures for both intervention groups. The effect of timing was further analyzed by 
a linear regression analysis comparing the effect of MIT versus delayed MIT. The T1-T2 MIT 
group improved significantly more on the ANELT (β=6.1, p=.02) and on the repetition of 
untrained items (β=7.97, p=.02) than the delayed MIT group.  
 
Determinants  
We examined the following possible determinants for therapy outcome: age, gender, severity 
of the aphasia, patients’ linguistic profile at the start of MIT (language repetition, auditory 
comprehension, semantic knowledge). None of these variables affected therapy outcome.  
 
Discussion 
This is the first study showing that MIT has a positive effect on language production in 
subacute aphasia: we found significantly more improvement on language repetition after MIT 
than after a control treatment of the same intensity, and starting at the same time post stroke. 
Further, the considerable difference on the ANELT between the MIT and the control group 
suggests that the effect of MIT is not limited to language repetition, but generalizes to verbal 
communication in daily life.  
The contrast between trained and untrained material, with a larger effect for trained material, 
is clinically relevant. These results underline the importance of carefully selecting utterances 
to be trained. MIT should be tailor-made, training sentences that are functionally relevant for 
the individual patient.. 
The timing of aphasia therapy is a clinically important issue. Many clinicians believe that 
earlier intervention yields larger improvement, although the evidence for early treatment is 
not yet well-established.
10,11
 In our study, we were able to assess the effect of delaying a 
specific therapy method. We found a clear effect of timing: a delay of only six weeks was 
related to less improvement, especially in tasks reflecting functional verbal language 
production.  
All patients fitted the clinical profile of MIT candidates. Still, large individual differences 
with respect to MIT success were found. In order to implement MIT more effectively in the 
clinical practice, stricter criteria are required. Unfortunately, we were unable to detect any 
determinants influencing therapy outcome.  
This study suggests that MIT is effective in severe aphasia in the subacute phase post stroke 
and that timing is an important factor related to MIT success. One of the limitations of the 
study is its small sample size. Larger group studies examining aphasia treatment in the early 
phases post stroke are badly needed to obtain more insight in clinically highly relevant issues 
as efficacy and timing of aphasia treatment in the first year post stroke.
12
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Mean score at T1, T2 and T3 on naming (A), ANELT (B) and Sabadel (C) 
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